Psychedelic-Assisted Therapy: The Psychotherapy Whose Time Has Come
Overview of psychedelic therapy research, training standards, neuroscience, global contexts, competencies and best practices for mental health professionals interested in integrating psychedelic-assisted psychotherapy.
Course Overview
As psychedelic medicines like MDMA and psilocybin near potential FDA approval, there is a growing need to train mental health professionals in psychedelic-assisted psychotherapy. This mini-course (75 minutes) provides an overview of the latest research showing the efficacy of psychedelic therapy for depression, anxiety, PTSD, addiction, and more.
Learn about the professional training programs being developed by MAPS and CIIS to prepare therapists to conduct safe, effective psychedelic sessions. Gain insights into neuropharmacology, global traditions, therapist competencies, and clinical best practices around psychedelic healing. An engaging discussion explores how psychedelic therapy is transforming mental healthcare and where it fits into innovative new treatments.
Whether you aim to provide psychedelic therapy or advise interested clients, this mini-course will equip you with knowledge of the research, competencies, and future potential of this emerging field.
Who is this for?
Counselors Social Workers Psychologists Psychotherapists Therapists Marriage & Family Therapists Addiction Counselors Case Managers Physicians Nurses Other Mental Health Professionals
About the Provider
PESI is a leading continuing education provider for mental health professionals, offering accredited online courses on psychedelic-assisted therapies including MDMA, psilocybin, ketamine, and microdosing, covering clinical frameworks, ethics, harm reduction, and client communication for therapists, counselors, nurses, and psychiatrists. Their trainings help clinicians build competence in this rapidly emerging therapeutic field and earn CE credits required for licensure.
View Pesi profileCourse Details
- Price$70
- FormatSelf-paced
- Lifecycle statusNo New Dates
- Skillspsychedelic psychotherapypsychedelic researchefficacytrainingPTSDdepressionanxietyaddictionneuropharmacologyglobal traditionscompetenciesbest practicesHarm ReductionFacilitation
- Categories
You will be redirected to the provider's website
Related Courses
View all coursesCertificate in Psychedelic-Assisted Therapies & Research | CIISCIIS LogoCIIS Logo
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
FDA On MDMA-Assisted Psychotherapy
This page discusses the FDA's rejection of MDMA-assisted psychotherapy and summarizes the rationale given for further research. It also reviews MDMA's history, reported therapeutic uses, and MAPS' response to the decision.
Automated status check: No valid upcoming cohort date found on the source page (checked 2026-04-15).
MAPS International MDMA-assisted Therapy Training Program
A collaboration between MAPS and the Clinical Psychedelic Lab at Monash University, this training program prepares mental healthcare professionals to support MDMA-assisted psychotherapy for PTSD. It combines online learning with a week-long in-person residential intensive and is limited to 65 trainees.
Automated status check: No valid upcoming cohort date found on the source page (checked 2026-04-15).